adamantane has been researched along with Cardiac Toxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, C; de Vries, F; Kothny, W; Lopez-Leon, S; Schlienger, R; Serban, C; Williams, R | 1 |
1 other study(ies) available for adamantane and Cardiac Toxicity
| Article | Year |
|---|---|
Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study.
Topics: Adamantane; Adult; Aged; Cardiotoxicity; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Europe; Female; Humans; Male; Middle Aged; Nitriles; Pyrrolidines; Retrospective Studies; Vildagliptin | 2017 |